Antibodies targeting “Programmed Cell Death Protein-1 (PD-1), Programmed Cell Death Ligand-1 (PD-L1), and Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4)” restore T-cell activity, allowing the immune system to identify and destroy tumours [4]. Here, CTLA4 is linked to neoplasm.